Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 July 2023 | Story Leonie Bolleurs | Photo André Damons
Dr Jerry Mofokeng
Dr Jerry Mofokeng wa Makhetha recently launched his second book, Nna Ke Monna, during an event at the UFS.

Award-winning actor and now author, Dr Jerry Mofokeng wa Makhetha, launched his second book Nna Ke Monna at an event hosted by the University of the Free State (UFS) Department of Library and Information Services (LIS), the African Languages Press, and the Academy for Multilingualism

The event took place on 19 July on the Bloemfontein Campus.

The book launch was held as part of a creative writing masterclass and drew notable attendees, including dignitaries from Lesotho. Among them was the Honourable Minister of Trade and Industry in Lesotho, Shelile Motaung, and the British High Commissioner in Lesotho, Harry MacDonald.

Earlier last week, Jeannet Molopyane, Director of LIS, and her team handed a copy of the book to the Vice-Chancellor and Principal, Prof Francis Petersen. 

Writing in Sesotho

Out of a collection of more than 200 000 books, only 16 000 are written in Sesotho. Dr Mofokeng wa Makhetha highlighted that the UFS should take a leading role in promoting the publication of African languages.

Addressing the importance of decolonising education, he asked, ‘how do you do that? “We need to go back to our language and our culture. This is what this book seeks to correct and heal,” he answered. 

Unlike his first book, I am a man, where he delved into his intricate relationship with masculinity, fatherhood, and identity, this new book is written in Sesotho, not English.

I do not want anybody reading this latest book to sit with a dictionary to understand it. It was written for the Basotho pallet, to be read by all members of the family.
“As a Sesotho, I have the authority to talk to the Basotho and I don’t want to do that in a manner that anyone must interpret what I am saying.”

He went on to explain that he chose to write this book in Sesotho, because – with the first book – he found that there are thoughts that are difficult to express in English. The English book was a compromise in many ways, and with this book he wanted to reclaim his authentic voice and really have fun.

MacDonald also contributed to the language discussion, saying that the way in which we express ourselves is coloured by our language. He said being able to work in one's own language, such as this book, is a crucial aspect of reflecting one's culture and facilitates faster learning during childhood.

Molopyane, regarded the event as an opportunity to restore the dignity of our languages. Building upon Molopyane's statement, Kego Phuthi, Marketing and Engaged Scholarship Assistant Director in LIS, added that the book launch is reflecting on the significance of literature as a catalyst of change. “The book is an extraordinary work that can change stereotypes and give voice to the voiceless.”
 
Healing masculinity 

In addition to addressing language, the book also emphasised the significance of manhood and the process of healing masculinity. “We are here to raise responsible men with integrity, not big boys,” Dr Mofokeng wa Makhetha said.

According to Nthabiseng Jafta, the publicist of Nna Ke Monna, this book was released one year after Dr Mofokeng wa Makhetha’s first book and coincided with the launch of the African Languages Press.

“During the process of working on the second book, Dr Mofokeng wa Makhetha guided me to reconnect with myself,” said Jafta. She also expressed pride in contributing to the potential impact of Sesotho literature in the nation.

In his address, the Honourable Minister Motaung shared the same sentiment, encouraging Dr Mofokeng wa Makhetha to continue publishing books that uplift the Basotho community.

  • The award-winning South African actor, who appeared in the films Cry, the Beloved Country, Mandela and De Klerk, and Tsotsi, received an honorary doctorate from the UFS in 2019 for his commitment to scholarship and his service to humanity. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept